Stay updated on Zenocutuzumab Clinical Trial in NRG1 Fusion
Sign up to get notified when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.

Latest updates to the Zenocutuzumab Clinical Trial in NRG1 Fusion page
- Check5 days agoChange DetectedThe 403 Forbidden page is replaced by the clinical trial record for the zenocutuzumab study, displaying its study design, eligibility criteria, locations, outcomes, and related information.SummaryDifference86%

- Check12 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide banner announces changes to NIH terminology and links to transition updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2, while the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden message instead of the full study content. This blocks access to core study details, eligibility criteria, locations, and related information previously visible on the record.SummaryDifference19%

Stay in the know with updates to Zenocutuzumab Clinical Trial in NRG1 Fusion
Enter your email address, and we'll notify you when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.